Study on the self‐setting property and the in vitro bioactivity of β‐Ca2SiO4

This study sought to investigate the physical and chemical properties of β-dicalcium silicate (β-Ca2SiO4) in order to evaluate its use as an injectable bioactive cement filler. Workable β-Ca2SiO4 pastes with a liquid-to-powder (L/P) ratio of 1.0–1.2 could be injected for 10–30 min (nozzle diameter 2.0 mm) and enabled initial setting times of 60–180 min. The setting process yielded cellular structures with compressive strengths of 4.8–28.8 MPa after 2–28 days. The paste was soaked in simulated body fluid (SBF), and the results demonstrated that it exhibited a moderate degradation and could induce carbonated hydroxyapatite formation. The ionic products of the paste dissolution enhanced a proliferative response of fibroblasts compared with the cells cultured alone, and this cement could also support adhesion and spreading of the mesenchymal stem cells. Finally, with the use of gentamicin as a model drug, it was found that a high dose of drug release from the paste was maintained for 14 days, and there was a sustained release over 4 weeks. This combination of properties indicates that the novel β-Ca2SiO4 cement might be suitable for potential applications in the biomedical field, preferentially as materials for bone/dental repair and controlled drug-delivery systems. © 2005 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater

[1]  J. Arntorp,et al.  Effect of varying surface patterns on antibiotic elution from antibiotic-loaded bone cement. , 1995, The Journal of arthroplasty.

[2]  D. Pichora,et al.  Biodegradable Controlled Antibiotic Release Devices for Osteomyelitis: Optimization of Release Properties , 1994, The Journal of pharmacy and pharmacology.

[3]  C. Kaps,et al.  Porcine mesenchymal stem cells , 2002, Cell and Tissue Research.

[4]  J. Llorens,et al.  Rheological properties of an apatitic bone cement during initial setting , 2001, Journal of materials science. Materials in medicine.

[5]  J. Klein-Nulend,et al.  Transforming growth factor-β1 incorporated during setting in calcium phosphate cement stimulates bone cell differentiation in vitro , 2000 .

[6]  X. Marchandise,et al.  Adsorption and release of insulin-like growth factor-I on porous tricalcium phosphate implant. , 2000, Journal of biomedical materials research.

[7]  W. Kondo,et al.  Rate and Mechanism of Hydration of β‐Dicalcium Silicate , 1979 .

[8]  R. Reis,et al.  Drug delivery therapies I General trends and its importance on bone tissue engineering applications , 2002 .

[9]  T. Wright,et al.  Intravertebral body reconstruction with an injectable in situ‐setting carbonated apatite: Biomechanical evaluation of a minimally invasive technique , 1999, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[10]  E. Ruoslahti,et al.  Transforming growth factor-beta in disease: the dark side of tissue repair. , 1992, The Journal of clinical investigation.

[11]  W. Bonfield,et al.  A comparative study on the in vivo behavior of hydroxyapatite and silicon substituted hydroxyapatite granules , 2002, Journal of materials science. Materials in medicine.

[12]  S. P. Chow,et al.  A novel injectable bioactive bone cement for spinal surgery: a developmental and preclinical study. , 2000, Journal of biomedical materials research.

[13]  M. Buggy,et al.  Bone cements and fillers: A review , 2003, Journal of materials science. Materials in medicine.

[14]  S. Brunauer,et al.  The Stoichiometry of the Hydration of β-Dicalcium Silicate and Tricalcium Silicate at Room Temperature , 1958 .

[15]  T Kitsugi,et al.  Solutions able to reproduce in vivo surface-structure changes in bioactive glass-ceramic A-W. , 1990, Journal of biomedical materials research.

[16]  E M Carlisle,et al.  Silicon: A Possible Factor in Bone Calcification , 1970, Science.

[17]  S. Goodman,et al.  Histological, chemical, and crystallographic analysis of four calcium phosphate cements in different rabbit osseous sites. , 1998, Journal of biomedical materials research.

[18]  L L Hench,et al.  Gene-expression profiling of human osteoblasts following treatment with the ionic products of Bioglass 45S5 dissolution. , 2001, Journal of biomedical materials research.

[19]  C. Hamanishi,et al.  Healing of segmental bone defects in rats induced by a beta-TCP-MCPM cement combined with rhBMP-2. , 1999, Journal of biomedical materials research.

[20]  T. Mitsuda,et al.  Highly Reactive β-Dicalcium Silicate: II, Hydration Behavior at 25°C Followed by 29Si Nuclear Magnetic Resonance , 1992 .

[21]  J O Hollinger,et al.  Biodegradable bone repair materials. Synthetic polymers and ceramics. , 1986, Clinical orthopaedics and related research.

[22]  J. Polak,et al.  Ionic products of bioactive glass dissolution increase proliferation of human osteoblasts and induce insulin-like growth factor II mRNA expression and protein synthesis. , 2000, Biochemical and biophysical research communications.

[23]  Matthias Epple,et al.  Biological and medical significance of calcium phosphates. , 2002, Angewandte Chemie.

[24]  J R van Horn,et al.  Backgrounds of antibiotic-loaded bone cement and prosthesis-related infection. , 2004, Biomaterials.

[25]  Julian R. Jones,et al.  Nodule formation and mineralisation of human primary osteoblasts cultured on a porous bioactive glass scaffold. , 2004, Biomaterials.

[26]  J. Lemaître,et al.  Mechanical characterization of brushite cements: a Mohr circles' approach. , 2000, Journal of biomedical materials research.

[27]  K. Sasaki,et al.  Highly Reactive β‐Dicalcium Silicate: IV, Ball‐Milling and Static Hydration at Room Temperature , 1992 .

[28]  M. Sivakumar,et al.  Preparation, characterization and in vitro release of gentamicin from coralline hydroxyapatite-gelatin composite microspheres. , 2002, Biomaterials.

[29]  T. Yoshikawa,et al.  Bone and soft tissue regeneration by bone marrow mesenchymal cells , 2001 .

[30]  I. Thurzo,et al.  Thermal, Structural, and Dielectric Properties of Cu‐Doped Ge‐S Glasses , 1979 .

[31]  Xuanyong Liu,et al.  Bioactivity of plasma sprayed dicalcium silicate coatings. , 2002, Biomaterials.

[32]  Jiang Chang,et al.  Synthesis and in vitro bioactivity of dicalcium silicate powders , 2004 .

[33]  J. Lu,et al.  Histological and biomechanical studies of two bone colonizable cements in rabbits. , 1999, Bone.

[34]  S A Goldstein,et al.  Skeletal repair by in situ formation of the mineral phase of bone. , 1995, Science.

[35]  David S Hungerford,et al.  The effect of silica-containing calcium-phosphate particles on human osteoblasts in vitro. , 2003, Journal of biomedical materials research. Part A.

[36]  H. Taylor.  726. Hydrated calcium silicates. Part I. Compound formation at ordinary temperatures , 1950 .

[37]  C. R. Howlett,et al.  Effect of rapidly resorbable calcium phosphates and a calcium phosphate bone cement on the expression of bone-related genes and proteins in vitro. , 2004, Journal of biomedical materials research. Part A.

[38]  S. Ghosh,et al.  The chemistry of dicalcium silicate mineral , 1979 .

[39]  Seong‐Hyeon Hong,et al.  Hydration kinetics and phase stability of dicalcium silicate synthesized by the Pechini process , 1999 .

[40]  T. Yamamuro,et al.  The bonding behavior of calcite to bone. , 1991, Journal of biomedical materials research.

[41]  J. Planell,et al.  Some factors controlling the injectability of calcium phosphate bone cements , 1998, Journal of materials science. Materials in medicine.

[42]  K. Schwarz,et al.  Growth-promoting Effects of Silicon in Rats , 1972, Nature.